BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li YH, Sun W, Zhou BJ, Rosenstein A, Zhao J, Wang J, Bian ZX. iTRAQ-based pharmacoproteomics reveals potential targets of berberine, a promising therapy for ulcerative colitis. Eur J Pharmacol 2019;850:167-79. [PMID: 30771347 DOI: 10.1016/j.ejphar.2019.02.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Cheng H, Liu J, Tan Y, Feng W, Peng C. Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine. Journal of Pharmaceutical Analysis 2021. [DOI: 10.1016/j.jpha.2021.10.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Ashrafizadeh M, Najafi M, Mohammadinejad R, Farkhondeh T, Samarghandian S. Berberine Administration in Treatment of Colitis: A Review. Curr Drug Targets 2020;21:1385-93. [PMID: 32564751 DOI: 10.2174/1389450121666200621193758] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Yuan Z, Yang L, Zhang X, Ji P, Hua Y, Wei Y. Huang-Lian-Jie-Du Decoction Ameliorates Acute Ulcerative Colitis in Mice via Regulating NF-κB and Nrf2 Signaling Pathways and Enhancing Intestinal Barrier Function. Front Pharmacol 2019;10:1354. [PMID: 31849642 DOI: 10.3389/fphar.2019.01354] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
4 Ma Y, Yan G, Guo J, Li F, Zheng H, Wang C, Chen Y, Ye Y, Dai H, Qi Z, Zhuang G. Berberine Prolongs Mouse Heart Allograft Survival by Activating T Cell Apoptosis via the Mitochondrial Pathway. Front Immunol 2021;12:616074. [PMID: 33732240 DOI: 10.3389/fimmu.2021.616074] [Reference Citation Analysis]
5 Jia L, Xue K, Liu J, Habotta OA, Hu L, Abdel Moneim AE. Anticolitic Effect of Berberine in Rat Experimental Model: Impact of PGE2/p38 MAPK Pathways. Mediators Inflamm 2020;2020:9419085. [PMID: 33061833 DOI: 10.1155/2020/9419085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
6 Han Q, Tang HZ, Zou M, Zhao J, Wang L, Bian ZX, Li YH. Anti-inflammatory Efficacy of Combined Natural Alkaloid Berberine and S1PR Modulator Fingolimod at Low Doses in Ulcerative Colitis Preclinical Models. J Nat Prod 2020;83:1939-49. [PMID: 32432470 DOI: 10.1021/acs.jnatprod.0c00175] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lin Y, Xiong W, Xiao S, Li F, Lu Z, Yan J, Fang X, Cui X, Wen Y, Liang J, Yu K. Pharmacoproteomics reveals the mechanism of Chinese dragon's blood in regulating the RSK/TSC2/mTOR/ribosome pathway in alleviation of DSS-induced acute ulcerative colitis. J Ethnopharmacol 2020;263:113221. [PMID: 32783984 DOI: 10.1016/j.jep.2020.113221] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Xiong X, Cheng Z, Wu F, Hu M, Liu Z, Dong R, Chen G. Berberine in the treatment of ulcerative colitis: A possible pathway through Tuft cells. Biomed Pharmacother 2021;134:111129. [PMID: 33348308 DOI: 10.1016/j.biopha.2020.111129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
9 Chen X, Wang Y, Ma N, Tian J, Shao Y, Zhu B, Wong YK, Liang Z, Zou C, Wang J. Target identification of natural medicine with chemical proteomics approach: probe synthesis, target fishing and protein identification. Signal Transduct Target Ther 2020;5:72. [PMID: 32435053 DOI: 10.1038/s41392-020-0186-y] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]